A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Raskob, Gary E
  • Van Es, Nick
  • Verhamme, Peter
  • Carrier, Marc
  • Di Nisio, Marcello
  • Garcia, David A
  • Grosso, Michael A
  • Kakkar, Ajay K
  • Kovacs, Michael J
  • Mercuri, Michele F
  • Meyer, Guy
  • Segers, Annelise
  • Shi, Minggao
  • Wang, Tzu-Fei
  • Yeo, Erik
  • Zhang, George
  • Zwicker, Jeffrey I
  • Weitz, Jeffrey
  • Buller, Harry R

publication date

  • December 7, 2017

published in